Lithium and psoriasis: What primary care and family physicians should know

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 10, Issue 6, 2008, Pages 435-439

  Jafferany, Mohammad ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; INOSITOL; KERATOLYTIC AGENT; LITHIUM; METHOTREXATE; METHOXSALEN; MOOD STABILIZER; OMEGA 3 FATTY ACID; PLACEBO; RETINOID DERIVATIVE; STEROID; VITAMIN D DERIVATIVE;

BIPOLAR DISORDER; CHRONIC INFLAMMATION; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; DEMYELINATING DISEASE; DISEASE SEVERITY; DRUG ACTIVITY; DRUG DOSE REDUCTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENERAL PRACTITIONER; HUMAN; INCIDENCE; LYMPHOPROLIFERATIVE DISEASE; MANIA; OPPORTUNISTIC INFECTION; PRIMARY MEDICAL CARE; PROPHYLAXIS; PSORIASIS; PUVA; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 58149148233     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.v10n0602     Document Type: Review

References (49)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
2. Vestergaard P, Amdisen A, Schou M. Clinically significant side effects of lithium treatment: a survey of 237 patients in long term treatment. Acta Psychiatr Scand 1980;62(3):193-200
3. Sarantidis D, Waters B. A review and controlled study of cutaneous conditions associated with lithium carbonate. Br J Psychiatry 1983;143:42-50
4. Chan HH, Wing Y, Su R, et al. A control study of the cutaneous side effects of chronic lithium therapy. J Affect Disord 2000 Jan-Mar;57(1-3):107-113
5. Selmanowitz VJ. Lithium, leukocytes and lesions. Clin Dermatol 1986;4(1):170-175
6. Cade JF. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949 Sep;2(10):349-352
7. Carter TN. The relationship of lithium carbonate to psoriasis. Psychosomatics 1972;13(5):325-327
8. Bakker JB, Pepplinkhuizen L. More about the relationship of lithium to psoriasis. Psychosomatics 1976;17:143-146
9. O'Brien, Koo J. The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J Drugs Dermatol 2006;5(5):426-432
10. Hwang SM, Ahn SK, Menon GK, et al. Basis of occlusive therapy in psoriasis: correcting defects in permeability barrier and calcium gradient. Int J Dermatol 2001;40(3):223-231
11. Odagaki Y, Koyama Y, Yamashita I. Lithium and serotonergic neural transmission: a review of pharmacological and biochemical aspects in animal studies. Lithium 1992;100:3-12
12. Hemlock C, Rosenthal JS, Winston A. Fluoxetine-induced psoriasis. Ann Pharmacother 1992;26:211-212
13. Voorhees JJ, Marcelo CL, Duell EA. Cyclic AMP, cyclic GMP and glucocorticoids as potential metabolic regulators of epidermal proliferation and differentiation. J Invest Dermatol 1975;65(1):179-190
14. Bloomfield FJ, Young MM. Enhanced release of inflammatory mediators from lithium-stimulated neutrophils in psoriasis. Br J Dermatol 1983;109(1):9-13
15. Grisaru N, Belmaker RH. Lithium dosage and inositol levels. Br J Psychiatry 1994;164(1):133-134
16. Allan SJ, Kavanagh GM, Herd RM, et al. The effect of inositol supplements on the psoriasis of the patients taking lithium: a randomized placebo-controlled trial. Br J Dermatol 2004;150(5):966-969
17. Rothstein G, Clarkson DR, Larsen W, et al. Effect of lithium on neutrophil mass and production. N Engl J Med 1978;298:178-180
18. Ockenfels HM, Wagner SN, Keim-Maas C, et al. Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium. Arch Dermatol Res 1996 Apr;288(4):173-178
19. Kniff EM, Kupka RW, Ruwhof C. Evidence that immunopathogenic mechanism of lithium-induced psoriasis differs from that of regular psoriasis. Bipolar Disord 2005;7:388-389
20. 3) on in-vitro cultured normal human skin explants. J Eur Acad Dermatol Venereol 2000;14:97-99
21. Ockenfels HM, Nussbaum G, Schultewolter T, et al. Tyrosine phosphorylation in psoriasis T cells is modified by drugs that induce or improve psoriasis. Dermatology 1995;191(3):217-225
22. Lin X-R, Huang T, Yang CM. Histological changes induced by application of lithium carbonate to mouse ear skin. Arch Dermatol Res 1990;282:280-281
23. Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007 Nov-Dec;25(6):606-615
24. Skerritt PW. Psoriatic arthritis during lithium therapy. Aust N Z J Psychiatry 1987;21:601-604
25. Bakker JB, Pepplinkhuizen L. More about the relationship of lithium: lithium carbonate and psoriasis. Am J Psychiatry 1979;136:1326-1327
26. Evans DL, Martin W. Lithium carbonate and psoriasis. Am J Psychiatry 1979;136:1326-1327
27. Deandrea D, Walker N, Mehlmauer M, et al. Dermatological reactions to lithium: a critical review of the literature. J Clin Psychopharmacol 1982;2:199-204
28. Yeung CK, Chan HHL. Cutaneous adverse effects of lithium. Am J Clin Dermatol 2004;5(1):3-8
29. Skoven I, Thormann J. Lithium compound treatment and psoriasis. Arch Dermatol 1979;115:1185-1187
30. Tsankov N, Angelova I, Kazandjieva J. Drug-induced psoriasis: recognition and management. Am J Clin Dermatol 2000;1(3):159-165
31. Jafferany M. Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry 2007;9(3):203-213
32. Pande AC, Max P, Donnelly RF. Lithium associated with psoriasis [letter]. J Clin Psychiatry 1986 Jun;47(6):330
33. Farber EM, Nall L. Pustular psoriasis. Cutis 1993 Jan;51(1):29-32
34. White SW. Palmoplantar pustular psoriasis provoked by lithium therapy. J Am Acad Dermatol 1982;7:660-662
35. Rudolph RI. Lithium induced psoriasis of the fingernails. J Am Acad Dermatol 1992;26(1):135-136
36. Hooper JF. Lithium carbonate and toenails [letter]. Am J Psychiatry 1981 Nov;138(11):1519
37. Don PC, Silverman RA. Nail dystrophy induced by lithium carbonate. Cutis 1988;41:19-21
38. Tsankov N, Kazandjieva JK, Drenovska K. Drugs in exacerbation and provocation of psoriasis. Clin Dermatol 1998;16:333-351
39. Abel EA, DiCicco LM, Orenberg EK, et al. Drugs in exacerbation of psoriasis. J Am Acad Dermatol 1986;15:1007-1022
40. Skott A, Magnusson BL, Mobacken H, et al. Lithium and psoriasis [letter]. Br J Psychiatry 1977 Aug;131:223
41. Lambert D, Beer F, Gisselman R, et al. Cutaneous lesions due to lithium therapy. Ann Dermatol Venereol 1982;109(1):19-24
42. Lowe NJ, Ridgway HB. Generalized pustular psoriasis precipitated by lithium carbonate. Arch Dermatol 1978;114:1788-1789
43. Sedgwick JB, Bergstresser PR, Hurd ER. Increased granulocyte adherence in psoriasis and psoriatic arthritis. J Invest Dermatol 1980;74(2):81-84
44. Al'Abadie MS, Kent CG, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994;130:199-203
45. Griffiths CE, Richards HL. Psychological influence in psoriasis. Clin Exp Dermatol 2001;26:338-342
46. Alvarez WA, Freinhar JP. Direct evidence for a lithium-induced psoriasis syndrome. Int J Psychosom 1984;31:21-22
47. Akkerhuis GW, Nolen WA. Lithium-associated psoriasis and omega-3 fatty acids [letter]. Am J Psychiatry 2003 Jul;160(7):1355
48. Wachter T, Murach WM, Brocker EB, et al. Recalcitrant lithium-induced psoriasis in a suicidal patient alleviated by tumor necrosis factor-alpha inhibition. Br J Dermatol 2007 Sep;157(3):627-629
49. Nash PT, Florin THJ. Tumour necrosis factor inhibitors. Med J Aust 2005;183(4):205-208